Below are the top small-cap diagnostic substances stocks on the NYSE and the NASDAQ in terms of earnings per share.
The trailing-twelve-month earnings per share at SurModics SRDX is $0.99. SurModics' operating margin for the same period is 34.40%.
The trailing-twelve-month earnings per share at Meridian Bioscience VIVO is $0.91. Meridian Bioscience's revenue for the same period is $188.70 million.
The trailing-twelve-month earnings per share at Abaxis ABAX is $0.84. Abaxis' PEG ratio is 5.15.
The trailing-twelve-month earnings per share at Neogen NEOG is $0.75. Neogen's ROE for the same period is 18.10%.
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in